2020
DOI: 10.1002/adma.202001452
|View full text |Cite
|
Sign up to set email alerts
|

Tumor‐Microenvironment‐Triggered Ion Exchange of a Metal–Organic Framework Hybrid for Multimodal Imaging and Synergistic Therapy of Tumors

Abstract: Nanotheranostic agents (NTAs) that integrate diagnostic capabilities and therapeutic functions have great potential for personalized medicine, yet poor tumor specificity severely restricts further clinical applications of NTAs. Here, a pro‐NTA (precursor of nanotheranostic agent) activation strategy is reported for in situ NTA synthesis at tumor tissues to enhance the specificity of tumor therapy. This pro‐NTA, also called PBAM, is composed of an MIL‐100 (Fe)‐coated Prussian blue (PB) analogue (K2Mn[Fe(CN)6]) … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
77
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 100 publications
(79 citation statements)
references
References 63 publications
1
77
0
1
Order By: Relevance
“…Prussian blue-based nanomaterials have shown promise for both PTT and Fenton-reaction mediated CDT [ 186 ]. In one study, MIL-100 (Fe) coated K 2 Mn[Fe(CN) 6 ] NPs (PBAM) were prepared for CDT and PTT combination therapy [ 187 ]. In the mildly acidic TME, the MIL-100 shell was degraded to release Fe 3+ , which further exchanged with Mn 2+ to synthesize Prussian blue for PTT.…”
Section: Fenton and Fenton-like Reactions-mediated Combination Therapymentioning
confidence: 99%
“…Prussian blue-based nanomaterials have shown promise for both PTT and Fenton-reaction mediated CDT [ 186 ]. In one study, MIL-100 (Fe) coated K 2 Mn[Fe(CN) 6 ] NPs (PBAM) were prepared for CDT and PTT combination therapy [ 187 ]. In the mildly acidic TME, the MIL-100 shell was degraded to release Fe 3+ , which further exchanged with Mn 2+ to synthesize Prussian blue for PTT.…”
Section: Fenton and Fenton-like Reactions-mediated Combination Therapymentioning
confidence: 99%
“…This MOF realized tumor targeted multimodal imaging (Near-infrared fluorescence images, PAI, and MRI). [20]. In the mildly acidic tumor microenvironment, the MIL-100 shell was degraded, and the released Fe 3+ exchanged with Mn 2+ to synthesize in situ the more stable PB, Fe 3+ -[Fe(CN)6] 4− , and to release free Mn 2+ .…”
Section: Mofs As Nanocarriersmentioning
confidence: 99%
“…The excellent PAI and PTT of PB, and T1-weighted MRI and CDT of Mn 2+ showed accurate theranostic effects (Figure 10). [20]. In the mildly acidic tumor microenvironment, the MIL-100 shell was degraded, and the released Fe 3+ exchanged with Mn 2+ to synthesize in situ the more stable PB, Fe 3+ -[Fe(CN)6] 4− , and to release free Mn 2+ .…”
Section: Mofs As Nanocarriersmentioning
confidence: 99%
“…纳米酶在肿瘤微环境响应的 CDT/PDT 中研究较多 [10][11][12] . 无机纳米材料具有优异的磁、光、电、声和热等响 应特性,可以作为智能响应型纳米酶,在肿瘤可视 化诊疗中显示出潜在的应用前景 [13] .韩国国立首尔大…”
Section: 作为一类具有类酶催化活性的纳米结构材料, 纳米 酶可以催化肿瘤微环境中的 内源 性物 质提供unclassified